Literature DB >> 1260993

Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation.

J L Bolen, E L Alderman.   

Abstract

Nitroprusside was used to reduce afterload in 13 patients with isolated, severe aortic regurgitation. The drug significantly lowered mean aortic pressure, pulse pressure, left ventricular end-diastolic pressure and left ventricular volume. Total ventricular, or angiographic, cardiac index was generally unaffected, but forward cardiac index was improved significantly in 8 of 13 patients. Augmentation of forward cardiac index was seen in patients with subnormal resting forward cardiac index, in patients with decidedly elevated end-diastolic pressure, and in those with depressed resting ejection fractions. Regurgitant fraction fell with nitroprusside in six patients and remained unchanged in seven. Total stroke work index was diminished in all patients. These data show that afterload reduction in patients with severe aortic regurgitation may improve hemodynamics by reducing aortic regurgitation or by improving ventricular pump function. The lowered total stroke work, reduced ventricular size and improved forward cardiac index imply that afterload reduction may benefit left ventricular failure and delay progressive ventricular dysfunction in patients with aortic regurgitation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1260993     DOI: 10.1161/01.cir.53.5.879

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

1.  Aortic Regurgitation.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-04

2.  Effect of load alterations on the effective regurgitant orifice area in chronic aortic regurgitation.

Authors:  Y J Kim; M Jones; T Shiota; H Tsujino; J X Qin; F Bauer; M Sitges; J Kwan; L A Cardon; A D Zetts; J D Thomas
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

3.  Role of vasodilators in regurgitant valve disease.

Authors:  Artur Evangelista; Pilar Tornos; Antonia Sambola; Gaieta Permayer-Miralda
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-12

Review 4.  [Aortic stenosis].

Authors:  W G Daniel; H Baumgartner; C Gohlke-Bärwolf; P Hanrath; D Horstkotte; K C Koch; A Mügge; H J Schäfers; F A Flachskampf
Journal:  Clin Res Cardiol       Date:  2006-11       Impact factor: 5.460

5.  Vasodilator treatment for acute and chronic heart failure.

Authors:  K Chatterjee; W W Parmley
Journal:  Br Heart J       Date:  1977-07

6.  The hemodynamic effects of acute aortic regurgitation into a stiffened left ventricle resulting from chronic aortic stenosis.

Authors:  Ikechukwu Okafor; Vrishank Raghav; Prem Midha; Gautam Kumar; Ajit Yoganathan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-22       Impact factor: 4.733

7.  Comparison of vasodilator drug prazosin with digoxin in aortic regurgitation.

Authors:  B E Hockings; G D Cope; G M Clarke; R R Taylor
Journal:  Br Heart J       Date:  1980-05

8.  Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.

Authors:  J Mehta; M Iacona; C J Pepine; C R Conti
Journal:  Br Heart J       Date:  1979-12

9.  Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure.

Authors:  P W Armstrong
Journal:  Can Med Assoc J       Date:  1979-10-06       Impact factor: 8.262

10.  Effects of sodium nitroprusside on left ventricular diastolic pressure-volume relations.

Authors:  B R Brodie; W Grossman; T Mann; L P McLaurin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.